← FDA Drug Approvals (Drugs@FDA)

LEUSTATIN

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 1993-02-26

Drug application

FDA Application #

NDA020229

Application type

New Drug Application

Brand name

LEUSTATIN

Generic name

Cladribine

Active ingredients

CLADRIBINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

JANSSEN PHARMS

First approval

1993-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown